1 Result(s)

Article

Palbociclib sensitizes ER-positive breast cancer cells to fulvestrant by promoting the ubiquitin-mediated degradation of ER-α via SNHG17/Hippo-YAP axis

Endocrine therapy is the anti-tumor therapy for human breast cancer but endocrine resistance was a major burden. It has been reported that Palbociclib and fulvestrant can be used in combination for the treatme...

Lei Lei, Yuan Huang, Lei Shi, Weiwu Ye, **anmei Lv… in Breast Cancer Research and Treatment (2024)